By Iain Gilbert
Date: Friday 18 Sep 2026
(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.
| Transaction in Own Shares | 18-Sep-2026 | 18:14 | RNS |
| Softcat | 18-Sep-2026 | 18:00 | RNS |
| Transaction in Own Shares | 18-Sep-2026 | 18:00 | RNS |
| Form 8.5 EPT/Non RI EASYJET PLC Replacement | 18-Sep-2026 | 17:42 | RNS |
| Form 8.3 - Rotork plc | 18-Sep-2026 | 17:41 | RNS |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor:Babcock | 19-Dec-2014 | Telegraph |
| Questor:N Brown | 12-Dec-2014 | Telegraph |
| Questor :Victrex | 11-Dec-2014 | Telegraph |
| Questor :Aberdeen Asset Management | 03-Dec-2014 | Telegraph |
| Price | 5,807.24 |
| Change Today | -80.09 |
| % Change | -1.36 % |
| 17-Sep-26 Close | 5,887.33 |
You are here: research